Congratulations to the Ampersand Capital Partners team on their investment in Julius Clinical Research! Candesic provided commercial due diligence to Ampersand Capital Partners.
Julius Clinical is a leading academic clinical CRO providing clinical trial services and real-world evidence studies to biopharma sponsors. This strategic partnership will enhance Julius Clinical capabilities in pioneering clinical research and support the development of new therapeutics on a global scale.
© Candesic 2024